Norges Bank
KROS icon

Norges Bank’s Keros Therapeutics KROS Stock Holding History

Norges Bank’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-64,900
Closed -$1.03M – 1801
2024
Q4 		$1.03M Buy
+64,900
New +$3.37M ﹤0.01% 1758
2024
Q1 		– Sell
-35,700
Closed -$1.42M – 1936
2023
Q4 		$1.42M Sell
35,700
-61,700
-63% -$1.93M ﹤0.01% 1827
2023
Q3 		$3.11M Buy
+97,400
New +$3.64M ﹤0.01% 1771
2021
Q4 		– Sell
-52,700
Closed -$2.08M – 2262
2021
Q3 		$2.08M Buy
+52,700
New +$1.88M ﹤0.01% 2043

Other funds holding KROS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return